Pharmacology and clinical evaluation of the anti-angiogenesis agent ramucirumab
MA Ying
WANG Ting
MA Yi-ming
LIN Bi-rong
Keywords：ramucirumabVEGFR2angiogenesisgastric cancergastro-esophageal junction adenocarcinoma
Publication Date：2014-01-01
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)